Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies - Wikidata - awgldk - TriplyDB

Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies

Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies

http://www.wikidata.org/entity/Q34042891

about

New Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney Disease Linking uric acid metabolism to diabetic complications Role of NADPH Oxidase in Metabolic Disease-Related Renal Injury: An Update Renin-Angiotensin System Inhibitor is Associated with Lower Risk of Ensuing Chronic Kidney Disease after Functional Recovery from Acute Kidney Injury.Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review.Gout after living kidney donation: correlations with demographic traits and renal complications Hyperuricemia increases the risk of acute kidney injury: a systematic review and meta-analysis.Serum Uric Acid and Progression of Kidney Disease: A Longitudinal Analysis and Mini-Review Management of Chronic Kidney Disease: The Relationship Between Serum Uric Acid and Development of Nephropathy Gender-related differences in the association between serum uric acid and left ventricular mass index in patients with obstructive hypertrophic cardiomyopathy.The impact of serum uric acid on the natural history of glomerular filtration rate: a retrospective study in the general population.Incidence and Simple Prediction Model of Hyperuricemia for Urban Han Chinese Adults: A Prospective Cohort Study.Clinical Effects of Topiroxostat on Renal and Endothelial Function in A Patient with Chronic Kidney Disease and Hyperuricemic Arteriolopathy: A Case Report.Is Hyperuricemia Overlooked when Treating Pediatric Tuberculosis Patients with Pyrazinamide?Relationship between uric acid levels and risk of chronic kidney disease in a retrospective cohort of Brazilian workers Time to target uric acid to retard CKD progression.Effects of uric-acid-lowering therapy on renal outcomes: the future looks promising.Hyperuricemia, Hypertension, and Chronic Kidney Disease: an Emerging Association.The metabolic syndrome and chronic kidney disease.Prevalence, awareness and treatment of chronic kidney disease among middle-aged and elderly: The China Health and Retirement Longitudinal Study.Chronic kidney disease among adult participants of the ELSA-Brasil cohort: association with race and socioeconomic position.Genetic and environmental influences on the associations between change in kidney function and changes in cardiometabolic factors in Koreans.Asymptomatic hyperuricemia and chronic kidney disease: Narrative review of a treatment controversial.Association between uric acid, cancer incidence and mortality in patients with type 2 diabetes: Shanghai diabetes registry study.Investigation of Metabolic Factors Associated with eGFR Decline Over 1 Year in a Japanese Population without CKD.Factors Associated with Benign Paroxysmal Positional Vertigo: A Chinese Case-Control Study.Podocyte Injury and Albuminuria in Experimental Hyperuricemic Model Rats.The potential renoprotection of xanthine oxidase inhibitors: Febuxostat versus allopurinol.Urate-Lowering Therapy Ameliorates Kidney Function in Type 2 Diabetes Patients With Hyperuricemia.Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus.Uric acid and incident chronic kidney disease in dyslipidemic individuals.The association between elevated serum uric acid level and an increased risk of renal function decline in a health checkup cohort in China.Metabolomics reveal mitochondrial and fatty acid metabolism disorders that contribute to the development of DKD in T2DM patients.Asymptomatic hyperuricemia: is it time to intervene?Cardiac and renal protective effects of urate-lowering therapy.Uric acid upregulates the adiponectin‑adiponectin receptor 1 pathway in renal proximal tubule epithelial cells.Serum uric acid levels contribute to new renal damage in systemic lupus erythematosus patients.Negative correlation between serum uric acid and kidney URAT1 mRNA expression caused by resveratrol in rats.

P2860

Q26739475-745FE874-614E-4FC5-A9BE-CCA8F72D9C13 Q26996416-8FB5A5B6-AE7E-4AEE-8BB1-6D7C1D3EAE7B Q28074668-269F86B9-474A-4445-9248-476C5AF5673F Q33559888-3A120AD2-3733-4888-9216-42A28622DD63 Q33770852-00DE4A1B-5F37-48A9-A38D-616EBE6076E4 Q33864537-B54A2A8C-9443-4D0C-8481-90D4A4F550BF Q34682703-FE110DBF-CEF5-4B7A-9E9D-AFD8E2F5D597 Q35908386-7F06B25D-F990-442D-9A87-C4FB061FD38E Q36251821-E0175422-CAF9-43DF-80BE-06490B4B8B46 Q36255567-90E0FD3E-2E9C-4320-AF9D-6F848A4860E7 Q36373688-BEC4262E-21AE-473C-848D-0990911E269A Q36769535-BE58FBC1-CC0B-4354-963D-76D314291259 Q36778413-0B78861B-FD28-4775-B318-6C75B745914B Q37628800-5172698D-C6A5-41EF-AE1B-E18E7718BB7E Q37653449-6888DF9E-DAA9-4C6F-941C-8FC6E08786B2 Q38542018-9B9AF242-330F-409E-BAD4-710C48142EE7 Q38632200-8A6286F2-70EF-4505-8DFD-56BA32F86AB0 Q38848997-E6422C29-82AA-412C-98A6-68D64C250620 Q38865454-3022C638-2BB8-4BFC-9D5F-FBD439ABAD06 Q38970541-C2F55FC9-A9A5-4A2C-ACF6-99D99AE42CAE Q39056509-75BBF19F-87A4-497B-8721-912783A803F4 Q40263778-06E5B04A-C816-447F-A32E-CBC5020DC44B Q40381846-67FD34C3-78B5-4592-977C-61A1B1E57BFB Q40684239-6510A23E-0EA2-4B71-8E43-1674F2C8F405 Q41026359-68391969-8591-41C6-A80C-B5B56870C3AF Q41309175-196DDD4D-7902-4415-BCFE-2302D783D7CA Q41389948-70D69C2E-50C0-47A2-A3F3-499009461805 Q41475695-2BFE259E-E9A0-4D2B-AFE7-5543FE351DBE Q42316455-3E8D5713-0547-49EA-B0D7-65F1B4CAB160 Q42356139-C83856ED-E232-4E3A-9C78-0663C8EF844E Q45158703-ED528FF2-741C-4C8B-ACB1-8D4651E70017 Q46981976-5AC5D62D-35D5-49F4-8A32-CD33D79CC134 Q47660459-E114D608-CCA8-4378-90F3-421937314107 Q47672033-BCFA8CCF-47FF-4BE1-B7FE-353A3A5C724E Q47733127-B9D4F292-2285-43F6-9BCF-04B591CE43B1 Q49588772-FB5AA5F9-2395-4520-9DD0-B7FDF9B21337 Q49616077-07C0F968-BC6A-465F-9AEE-0BF961C8BD84 Q49849139-24FEA228-9A4A-438F-8355-64705FE9DB97 Q50946034-3AE98CAE-4572-4CD4-B93F-3E5982E822A1 Q51005757-87285A3E-F6F3-4885-A571-CB7B49D7FB80

P2860

Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies

http://www.wikidata.org/entity/Q34042891

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Is hyperuricemia an independen ...... n observational cohort studies

@ast

Is hyperuricemia an independen ...... n observational cohort studies

@en

Is hyperuricemia an independen ...... n observational cohort studies

@nl

type

label

Is hyperuricemia an independen ...... n observational cohort studies

@ast

Is hyperuricemia an independen ...... n observational cohort studies

@en

Is hyperuricemia an independen ...... n observational cohort studies

@nl

prefLabel

Is hyperuricemia an independen ...... n observational cohort studies

@ast

Is hyperuricemia an independen ...... n observational cohort studies

@en

Is hyperuricemia an independen ...... n observational cohort studies

@nl

P1433

Q34042891-456A91FC-E8A6-4D8E-8B3C-8B551D95ABE3

P1476

Q34042891-0FE645A5-86BA-41D0-A886-F152DDF12242

P2093

Q34042891-046C3EF4-027D-4A6C-9D08-BA348E2C5C5D

Q34042891-41AC5BC5-57F9-46D1-B534-88E125D042E5

Q34042891-642E3E9D-66A2-445F-8C44-3A5E17D63333

Q34042891-76585F6C-8D90-46C1-B775-FB73EB8C53E9

Q34042891-9096D8CE-E170-4C7B-87BF-00F206143293

Q34042891-CDBCD981-7179-4884-84F5-F33C570245DA

P275

Q34042891-D8B65524-F8B1-4DF8-9415-8267F01E0CD0

P2860

Q34042891-02EC8500-A40E-48FC-98F7-DBD10A5B76D3

Q34042891-0E69AE6D-E03E-46D5-B9B8-291C39C70544

Q34042891-109B50B0-5EDD-45B5-96D1-9DCA4579D486

Q34042891-184BF4E1-62E9-41B6-817D-17F53DC9F067

Q34042891-22900161-DD06-4CF0-899F-95D4BBC5FF2C

Q34042891-2889E965-954D-43B1-9B73-9E66E370ADC0

Q34042891-2A0CC3E7-24E0-464E-BA99-C77A277EE5BE

Q34042891-2E2A01BD-6A6B-4777-B97E-79F5BAF0CA8C

Q34042891-405F1A23-493C-449F-9BF1-630F3FA60858

Q34042891-4563549E-395C-4846-A48B-D5643573C059

P304

Q34042891-5E8D12F9-E15F-48E4-9F89-4F54129640EB

P31

Q34042891-8F465987-FE52-49AA-97F3-F0621213FEEF

Q34042891-9acab4c4-2afa-41cc-8ab5-f1f870fdb451

Q34042891-DDACD8D4-0655-4993-9684-9B877A2E9935

P356

Q34042891-66A7EE23-7462-412C-B29B-41D3695C4AE5

P478

Q34042891-0E29556E-9BE3-429A-8832-DA2808D965E7

P5008

Q34042891-FC3B0F79-475F-419D-A9A5-9D5AE0C42C53

P577

Q34042891-AF49DDA7-3F53-41F5-A97A-56F5DBD88F00

P5875

Q34042891-8B193283-2BD1-4697-99A3-153FE148D940

P698

Q34042891-98ECDC2D-9860-4C26-821D-FB4B9F1E8DBD

P921

Q34042891-5143644F-ADA1-4168-A8A5-F333C357D37B

Q34042891-5EDE9F93-F834-48DE-AD15-EFD835CF7A04

Q34042891-A71473F4-91DE-4DEA-9F97-B29E9CCEAA1D

Q34042891-B3F784D4-A8C6-438D-8763-4034095949AC

P932

Q34042891-933352DD-7797-4ACB-ACB7-C1C0AC0F3718

P356

1471-2369-15-122

P1433

P1476

Is hyperuricemia an independen ...... n observational cohort studies

@en

P2093

Chen Yang

http://www.w3.org/2001/XMLSchema#string

Fang Liu

http://www.w3.org/2001/XMLSchema#string

Ling Li

http://www.w3.org/2001/XMLSchema#string

Ping Fu

http://www.w3.org/2001/XMLSchema#string

Xiaoxi Zeng

http://www.w3.org/2001/XMLSchema#string

Yuliang Zhao

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

Metabolic syndrome and kidney disease: a systematic review and meta-analysis

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

Association between asymptomatic hyperuricemia and new-onset chronic kidney disease in Japanese male workers: a long-term retrospective cohort study.

Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study.

Identification of patients and risk factors in chronic kidney disease--evaluating risk factors and therapeutic strategies.

Hyperuricemia is an independent risk factor for new onset micro-albuminuria in a middle-aged and elderly population: a prospective cohort study in taiwan.

Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function.

Uric acid as a target of therapy in CKD.

Hyperuricemia and associated diseases.

Uric acid and incident kidney disease in the community.

P304

122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2369-15-122

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2014-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264291421

http://www.w3.org/2001/XMLSchema#string

P698

25064611

http://www.w3.org/2001/XMLSchema#string

P921

chronic kidney disease

P932

4132278

http://www.w3.org/2001/XMLSchema#string